|Articles|November 6, 2020
Mass Spectrometric Characterization of Antibody-siRNA Conjugates using the Agilent 6545XT AdvanceBio LC/Q-TOF
Author(s)Agilent Technologies, Inc.
Small interfering RNAs (siRNAs) are a promising type of RNA-based therapeutic drugs that demonstrate effectiveness on gene silencing through RNA interference (RNAi).
Related Content
Trending on LCGC International
1
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
2
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
3
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
4
Industry Roundup: Thermo Fisher Scales Orbitrap Platform Across Research, Biopharma, and Environmental Testing at ASMS 2026
5